The PaldiSpot test detects the presence of Borrelia, Babesia and Bartonella genospecies in a patient’s DNA.
Working from our world-class facilities in Europe, our scientists use the latest sensitive molecular biology technique called quantitative polymerase chain reaction (qPCR) to analyse DNA extracted from a blood sample to screen for the presence 23 of the most common strains of Borrelia, Babesia and Bartonella genospecies.
Used in combination with our PrimeSpot test, the PaldiSpot test provides critical information that can inform the development of personalised treatments and therapies for Lyme disease, improving patient outcomes.
The PaldiSpot test is clinically validated and highly accurate. It is suitable for adults aged 18 and over. Results are processed and returned to you within 14 days.
Purpose of the test
The PaldiSpot test analyses DNA extracted from blood cells and serum to screen for 23 of the most common strains of Borrelia, Babesia and Bartonella.
The patient’s DNA is used in quantitative polymerase chain reaction (qPCR) testing. qPCR is an advanced laboratory technique that monitors the amplification of a specific DNA molecule. During the PaldiSpot test, we examine each sample for the presence of 23 Borrelia, Babesia and Bartonella genospecies.
To ensure the reliability of results we perform all reactions in triplicate and conduct positive and negative controls for every strain.
The final report provides information on whether a specific strain is present in a patients cells or serum, and a quantification parameter (its Ct value, or threshold cycle).
On ordering the PaldiSpot test, you will receive a sample collection kit in the mail.
In the box, you will find step-by-step instructions on the sample requirements (blood sample or swab) and details on how to return the sample to us. We have strict internal controls to ensure that all samples are protected throughout the process.
Results are processed and returned within 14 days.
Support and training
At Biocentaur, we provide ongoing training and support for clinicians on how to conduct tests and interpret the results for patients. If you would like more information on the PaldiSpot test or any of the Biocentaur range of advanced genetic tests, please visit our FAQs page or contact us.
Download a sample report here.
Our PaldiSpot test costs £800.